lobbying_activities: 1990720

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1990720	961401e7-5ec9-440e-8615-86611f3549ef	Q2	KING & SPALDING LLP	21632	SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.)	2017	second_quarter	PHA	Issues related to inclusion of prescription drugs within Essential Health Benefit and mental health coverage expansion	HOUSE OF REPRESENTATIVES,SENATE			0	0	2017-07-18T09:51:17.800000-04:00